You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行报告》花旗升康哲药业(00867.HK)评级至「买入」 目标价上调至26元
阿思达克 03-18 10:13
花旗发表研报,将康哲药业(00867.HK)评级由「中性」上调至「买入」,预期医学美容业务将维持表现强劲,与大健康业务一同成为未来新增长引擎。

康哲药业上月宣布收购皮肤线专业公司Luqa Ventures全部股权,该行指出,公司已独立发展皮肤科及医学美容业务,预期将继续投资以加强产品线,未来几年料持续增聘人手,并拓展美容院、分销商、电商平台等销售渠道。

花旗指,公司目前每年取得5种创新药物授权,包括今年计划在中国推出癫痫用喷剂等,预期将持续为收入带来贡献,目标价由11.1元升至26元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account